BioSpace News Archive

Tetra Bio-Pharma Inc. are pleased to announce that they have finalized a definitive commercial sales agreement for the sale of the Mighty Medic device as part of the CAUMZ™-kit drug-device combination product.

Decision Diagnostics Corp. through its subsidiary Pharma Tech Solutions, Inc. made available CEO Keith Berman’s recent interview on radio station CKNW, Vancouver’s #1 rated News/Talk Radio station in the adult 35-64 sector.

Biomarkers are vital for identifying diseases in the human body. They are vital to the healthcare sector. The use of biomarkers in drug development also plays a vital role in the discovery of various drugs and vaccines necessary for curing a specific disease or disorder.

LogicBio Therapeutics, Inc., a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, announced that its 2020 Annual Meeting of Stockholders will be held in a virtual-only format due to continued public health concerns related to coronavirus / COVID-19, and to support the health and well-being of our stockholders and other meeting participants.

Healios K.K., Japan’s leading clinical-stage biotechnology company, has been creating Universal Donor Cells, which are next-generation iPS cells created with gene-editing technology to engineer a low risk of immune rejection regardless of HLA types.

The Supervisory Board of B. Braun SE announced that Caroll H. Neubauer will retire at the end of August 2020 after thirty-two years of distinguished service to B. Braun, including twenty-nine years serving on the Management Board of the B. Braun Group.